Although the Company continues to intersect copper-gold-silver mineralization that is consistent with carbonate replacement ( ...

Presented new subgroup analyses from phase 3 clinical trial of CAN-2409 in localized prostate cancer at the American Society ...

Discovery Silver Corp. (TSX: DSV, OTCQX: DSVSF) (“Discovery” or the “Company”) today to reported initial results from four key exploration projects at the ...

Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on ...

This NDA submission is an important milestone, and it brings gedatolisib one step closer to becoming available for patients with HR+/HER2- advanced breast cancer,” said Brian Sullivan, CEO and ...

Ontinue, a leading provider of agentic AI-powered managed extended detection and response (MXDR) services and winner of the 2023 Microsoft Security Services Innovator of the Year award, today ...

Medera is a clinical-stage biopharmaceutical company focused on targeting difficult-to-treat and currently incurable diseases by developing a range of next-generation therapeutics. Medera operates via ...

An updated edition of the September 19, 2025 article.A wide moat describes companies with durable competitive advantages that ...

Developed by Ascentage Pharma, lisaftoclax is an orally available Bcl-2 inhibitor. Early data from the studies have demonstrated effects on hematologic malignancies and solid tumors. Lisaftoclax is ...

London, UK, 13 November 2025 - IMU Biosciences (or "the Company”), a biotechnology company decoding the immune system to drive next generation health outcomes, today announced the formation of its ...